Paul C. Anderson
Direttore Tecnico/Scientifico/R&S presso Inception IBD, Inc.
Posizioni attive di Paul C. Anderson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | 10/12/2015 | - |
Storia della carriera di Paul C. Anderson
Precedenti posizioni note di Paul C. Anderson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2011 | - |
| The Chemical Institute of Canada | Corporate Officer/Principal | - | - |
Syndexa Pharmaceuticals Corp.
 Syndexa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Syndexa Pharmaceuticals Corp. developed novel medicines for the treatment and prevention of metabolic diseases. The company was founded in 2005 and was headquartered in Watertown, MA. | Corporate Officer/Principal | 17/12/2009 | - |
Formazione di Paul C. Anderson
| University of Western Ontario | Undergraduate Degree |
| University of Alberta | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 4 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Syndexa Pharmaceuticals Corp.
Syndexa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Syndexa Pharmaceuticals Corp. developed novel medicines for the treatment and prevention of metabolic diseases. The company was founded in 2005 and was headquartered in Watertown, MA. | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| The Chemical Institute of Canada | |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Commercial Services |
- Borsa valori
- Insiders
- Paul C. Anderson
- Esperienza
